Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Is Expected to Increase to US $25 Bn by 2024
ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines "neurobehavioral" as the way the brain affects emotion, behavior, and learning.
View full press release